Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Home
David V. Sheehan: An Open-Label Study of Tiagabine in Panic Disorder
David V. Sheehan: An Open-Label Study of Tiagabine in Panic Disorder
$
30.00
David V. Sheehan: An Open-Label Study of Tiagabine in Panic Disorder quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
SKU:
pb-40-3-sheehan
Categories:
Psychopharmacology Bulletin
,
VOL 40 No. 3 Articles
Tags:
aminobutyric-acid-gaba
,
anxiety
,
b-ashok-raj
,
david-v-sheehan
,
juris-janavs
,
kathy-harnett-sheehan
,
mba
,
md
,
panic-disorder
,
phd
,
selective-gaba-reuptake-inhibitor
,
tiagabine
Description
Description
David V. Sheehan, MD
Link
NEGATIVE AND FAILED CLINICAL TRIAL REPORTS
An Open-Label Study of Tiagabine in
Panic Disorder
David V. Sheehan, MD, MBA, Kathy Harnett Sheehan, PhD, B. Ashok Raj, MD, and Juris Janavs, MD
Related products
A Pilot Evaluating Clinical Pharmacy Services in an Ambulatory Psychiatry Setting
$
30.00
Add to cart
Details
Single Dose and Repeat Once-Daily Dose Safety, Tolerability and Pharmacokinetics of Valbenazine in Healthy Male Subjects
$
0.00
Add to cart
Details
Assessment of Anxiety in Clinical Trials with Depressed Patients
$
30.00
Add to cart
Details
Stellate Ganglion Blocks for Post-Traumatic Stress Disorder: A Review of Mechanisms, Efficacy, and Complications
$
30.00
Add to cart
Details
Page load link
Go to Top